Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | 30,710 | N/A |
| Receivables | N/A | N/A | N/A | 3,740 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $36,280 | $N/A |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 18,580 | N/A |
| Intangibles | 0 | 0 | 0 | 13,420 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 410 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $32,410 | $N/A |
| Total Assets | $N/A | $N/A | $N/A | $57,570 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 1,440 | 0 |
| Accrued Expenses | N/A | N/A | N/A | 7,250 | N/A |
| Other current liabilities | N/A | N/A | N/A | 6,460 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $16,320 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 6,462 | N/A |
| Other Non-Current Liabilities | 125 | 145 | 78 | -160 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $68,930 | $N/A |
| Total Liabilities | $N/A | $N/A | $N/A | $85,250 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 110 | N/A |
| Retained earnings | N/A | N/A | N/A | -271,610 | N/A |
| Other shareholders' equity | 0 | 0 | 0 | 192,280 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $-27,680 | $N/A |
| Total Liabilities And Equity | $0 | $0 | $0 | $57,570 | $0 |